Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Orally active androgens

Orally active androgens

US Patent 6780854 · Granted Aug 24, 2004

Estimated economic value: $9,507,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Ring-annulated dihydropyrrolo[2,1-α]isoquinolines2013
(Dihydro)pyrrolo[2,1-α]isoquinolines2013
Substituted 16,17-annellated steroid compounds for use in womens healthcare2013
(Dihydro)imidazoiso[5,1-A]quinolines2011
Dihydrobenzoindazoles2011
16,17-carbocyclic condensed steroid compounds having selective estrogenic activi2011
15 β-substituted steroids having selective estrogenic activity2010
16Alpha-methyl or ethyl substituted estrogens2010
Steroids having a mixed androgenic and progestagenic profile2009
Estrogenic estra-1,3,5(10)-trienes with differential effects on the alpha and be2009
Substituted 10-aryl-11H-benzo[b]fluorenes and 7-aryl-5, 6-dihydro-benzo[a]anthra2008
Etonogestrel esters2008